Clinical-grade 503B peptides + DNA-driven personalization for modern medical practices.
503B Pharmacy Sourced
Pathway Based DNA Analysis
Built for Practicioner Use
HIPAA Compliant

Research Issues
There are inconsistencies in the reporting process.
Protocol Problems
Most protocols ignore patient biology and may not resolve the key problems.
DNA Reporting Issues
Some DNA analysis options rely solely on AI Driven scoring-not real pathways.
Sourced through a federally regulated 503B pharmacy for human clinical use—ensuring consistency, sterility, and reliability.
Pathway-driven analysis focusing on inflammation, methylation, neurocognitive health, and metabolic efficiency. No algorithm-based scoring. Real biological interpretation.
Clinical frameworks, protocols, and tools designed to help you integrate peptides and DNA into your practice.
Higher patient retention.
Differentiation in a crowded market
More consistent outcomes
Premium service positioning
This treatment model is easily scalable!
Request Access
Set up a quick call
Integrate your practice
Copyrights 2026 | OptiHelix Health | [email protected] | Privacy Policy